Type 2 diabetes and cardio-renal complications programme

Last update: 10/06/2022

Cardiovascular and kidney disease are the two most common and life-threatening complications of type 2 diabetes (T2D). However, global data on prevalence, quality of care and outcomes for people living with these complications are not widely available.

Diabetes and diabetes complications registries can help deliver better care, decrease healthcare expenditure and save lives. Registries also facilitate epidemiological research that helps to identify trends and inform campaigns to bring about policy change to improve the lives of people living with diabetes.

The absence of registries and epidemiological data on T2D diabetes and cardio-renal complications is particularly apparent in low- and middle-income countries. To address the shortfall, IDF has initiated the T2D and cardio-renal complications programme. The initiative aims to:

  • Put diabetes registries in the hands of healthcare professionals (HCPs) in low- and middle-income countries.
  • Advocate for policies that improve quality of care.
  • Raise awareness of the risk and potential consequences of cardio-renal complications in people living with diabetes.

IDF invites HCPs to join the iCaReMe registry, a real-world, evidence-based international observational study that collects data on cardio-renal complications in people with type 2 diabetes. The registry provides a cloud-based tool for healthcare professionals to track data and follow up on their patients with diabetes and cardio-renal complications.

To be eligible for inclusion in the study, patients must meet the following criteria:

  • Be over 18 years of age.
  • Have type 2 diabetes and cardio-renal complications (heart failure, chronic kidney disease).
  • Provide written informed consent of their willingness to participate in the study.

For more information on the T2D and cardio-renal complications programme, including access to the registry and advice on how to participate in the study, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..

iCaReMe logo   1
© 2022 International Diabetes Federation Disclaimer Privacy policy